Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SYK · against 27 other Healthcare companies of similar size
Ranked #15 of 28 · scores higher than 48% of peers · safety percentile 30
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)8 peers with a safety percentile of 30–39, including SYK · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SYK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 24 reported | 0.64× | 0.64× | 48% | 33% | |
| BetaLower is better · 28 reported | 0.77 | 0.44 | 19% | 33% | |
| Current ratioHigher is better · 28 reported | 2.16× | 1.32× | 74% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 100.2B USD | 77 | 68 | |
| 2 | 11.26T JPY (≈$76.6B) | 74 | 72 | |
| 3 | 134.5B USD | 72 | 70 | |
| 4 | 534.1B HKD (≈$68.4B) | 58 | 75 | |
| 5 | 108.6B USD | 51 | 66 | |
| 11 | 63.0B USD | 34 | 65 | |
| 12 | 177.5B USD | 33 | 71 | |
| 13 | 171.0B USD | 33 | 45 | |
| 14 | 161.8B USD | 32 | 50 | |
| 15 | 119.1B USD | 30 | 57 | |
| 16 | 189.3B USD | 30 | 45 | |
| 17 | 78.1B USD | 30 | 60 | |
| 18 | 89.7B USD | 27 | 50 | |
| 19 | 95.4B AUD (≈$62.9B) | 24 | 48 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score